This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Jan;18(1):67-80.

doi: 10.1055/s-2007-1002412.

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

C Krishnamurti¹, B M Alving

Affiliations

PMID: 1374195
DOI: 10.1055/s-2007-1002412

Review

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

C Krishnamurti et al. Semin Thromb Hemost. 1992 Jan.

. 1992 Jan;18(1):67-80.

doi: 10.1055/s-2007-1002412.

Authors

C Krishnamurti¹, B M Alving

Affiliation

¹ Division of Medicine, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.

PMID: 1374195
DOI: 10.1055/s-2007-1002412

No abstract available

PubMed Disclaimer

Similar articles

[Plasminogen activator inhibitors from neoplastic tissues].
Mirowski M, Wierzbicki R. Mirowski M, et al. Postepy Hig Med Dosw. 1991;45(1-2):119-27. Postepy Hig Med Dosw. 1991. PMID: 1923993 Review. Polish.
[Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J, Rueda F. Félez J, et al. Sangre (Barc). 1985;30(4-C):779-86. Sangre (Barc). 1985. PMID: 3937250 Spanish. No abstract available.
Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N. Moniwa N. Pol J Pharmacol. 1996 Mar-Apr;48(2):215-20. Pol J Pharmacol. 1996. PMID: 9112654
[Natural inhibitors of fibrinolysis].
Juhan-Vague I, Aillaud MF, Serradimigni A. Juhan-Vague I, et al. Haemostasis. 1986;16 Suppl 4:16-20. doi: 10.1159/000215527. Haemostasis. 1986. PMID: 3095197 French. No abstract available.
[Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F. Bachmann F. Arzneimittelforschung. 1988 Mar;38(3A):474-8. Arzneimittelforschung. 1988. PMID: 3134901 Review. German.

See all similar articles

Cited by

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
Albo D, Rothman VL, Roberts DD, Tuszynski GP. Albo D, et al. Br J Cancer. 2000 Aug;83(3):298-306. doi: 10.1054/bjoc.2000.1268. Br J Cancer. 2000. PMID: 10917542 Free PMC article.
Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
Albo D, Berger DH, Vogel J, Tuszynski GP. Albo D, et al. J Gastrointest Surg. 1999 Jul-Aug;3(4):411-7. doi: 10.1016/s1091-255x(99)80058-4. J Gastrointest Surg. 1999. PMID: 10482694
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Feener EP, Northrup JM, Aiello LP, King GL. Feener EP, et al. J Clin Invest. 1995 Mar;95(3):1353-62. doi: 10.1172/JCI117786. J Clin Invest. 1995. PMID: 7883982 Free PMC article.
Plasminogen Activator Inhibitors in Thrombosis: Structural Analysis and Potential Natural Inhibitors.
Dos Santos RV, Barrionuevo MVF, Vieira MRF, Mazoni I, Tasic L. Dos Santos RV, et al. ACS Omega. 2025 Jun 19;10(25):27348-27362. doi: 10.1021/acsomega.5c02926. eCollection 2025 Jul 1. ACS Omega. 2025. PMID: 40620932 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
Other Literature Sources
- The Lens - Patent Citations Database